6-Keto prostaglandin F1α, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period
- 1 January 1985
- journal article
- research article
- Published by Elsevier
- Vol. 151 (1) , 121-127
- https://doi.org/10.1016/0002-9378(85)90437-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (557380, 57570607)
This publication has 20 references indexed in Scilit:
- MATERNAL PLASMA PROSTACYCLIN CONCENTRATION IN PRE‐ECLAMPSIA AND OTHER PREGNANCY COMPLICATIONSBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- PROSTACYCLIN AND PRE-ECLAMPSIAThe Lancet, 1981
- REDUCTION OF FETAL VASCULAR PROSTACYCLIN ACTIVITY IN PRE-ECLAMPSIAThe Lancet, 1980
- Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaProstaglandins, 1980
- Prostacyclin in pregnancy.BMJ, 1980
- Prostacyclin and human foetal circulationProstaglandins, 1979
- The cardiovascular pharmacology of prostacyclin (PGI2) in the ratProstaglandins, 1979
- Prostaglandin I2 has more potent hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive ratProstaglandins, 1978
- COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITSBritish Journal of Pharmacology, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976